LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
95 hedge funds and large institutions have $891M invested in La Jolla Pharmaceutical Company in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
60% less call options, than puts
Call options by funds: $2.17M | Put options by funds: $5.47M
Holders
95
Holding in Top 10
5
Calls
$2.17M
Puts
$5.47M
Top Buyers
| 1 | +$58.5M | |
| 2 | +$8.43M | |
| 3 | +$6.51M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$5.39M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.6M |
Top Sellers
| 1 | -$7.97M | |
| 2 | -$7.74M | |
| 3 | -$7.49M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$5.51M |
| 5 |
BC
Broadfin Capital
New York
|
-$4.73M |